These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12759159)
1. Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders. Ramacciotti CE; Coli E; Paoli R; Marazziti D; Dell'Osso L Psychiatry Res; 2003 May; 118(1):33-8. PubMed ID: 12759159 [TBL] [Abstract][Full Text] [Related]
2. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers. Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403 [TBL] [Abstract][Full Text] [Related]
3. Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa. Ekman A; Sundblad-Elverfors C; Landén M; Eriksson T; Eriksson E Psychiatry Res; 2006 Jun; 142(2-3):219-23. PubMed ID: 16690136 [TBL] [Abstract][Full Text] [Related]
4. Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology. Bruce KR; Steiger H; Ng Ying Kin NM; Israel M Psychiatry Res; 2006 Jun; 142(2-3):225-32. PubMed ID: 16697471 [TBL] [Abstract][Full Text] [Related]
5. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment. Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977 [TBL] [Abstract][Full Text] [Related]
6. Platelet serotonin transporter and 5-HT2A receptor binding in adolescents with eating disorders. Sigurdh J; Allard P; Spigset O; Hägglöf B Int J Neurosci; 2013 May; 123(5):333-8. PubMed ID: 23360120 [TBL] [Abstract][Full Text] [Related]
7. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers. Patkar AA; Gopalakrishnan R; Berrettini WH; Weinstein SP; Vergare MJ; Leone FT Psychopharmacology (Berl); 2003 Mar; 166(3):221-7. PubMed ID: 12589524 [TBL] [Abstract][Full Text] [Related]
8. Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients. Marazziti D; Dell'Osso B; Baroni S; Betti L; Catena M; Giannaccini G; Lucacchini A; Cassano GB Pharmacopsychiatry; 2006 Jan; 39(1):35-8. PubMed ID: 16453253 [TBL] [Abstract][Full Text] [Related]
9. Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression. Maes M; Lin AH; Verkerk R; Delmeire L; Van Gastel A; Van der Planken M; Scharpé S Neuropsychopharmacology; 1999 Feb; 20(2):188-97. PubMed ID: 9885798 [TBL] [Abstract][Full Text] [Related]
10. Reduced density of platelet-binding sites for [3H]paroxetine in remitted bulimic women. Steiger H; Richardson J; Israel M; Ng Ying Kin NM; Bruce K; Mansour S; Marie Parent A Neuropsychopharmacology; 2005 May; 30(5):1028-32. PubMed ID: 15841087 [TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity. Preuss UW; Soyka M; Bahlmann M; Wenzel K; Behrens S; de Jonge S; Krüger M; Bondy B Psychiatry Res; 2000 Sep; 96(1):51-61. PubMed ID: 10980326 [TBL] [Abstract][Full Text] [Related]
12. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age. Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949 [TBL] [Abstract][Full Text] [Related]
13. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder. Coccaro EF; Lee R; Kavoussi RJ J Psychiatr Res; 2010 Feb; 44(3):137-42. PubMed ID: 19767013 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls. Faludi G; Tekes K; Tóthfalusi L J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562 [TBL] [Abstract][Full Text] [Related]
18. Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa. Steiger H; Israël M; Gauvin L; Ng Ying Kin NM; Young SN Psychiatry Res; 2003 Oct; 120(3):219-29. PubMed ID: 14561433 [TBL] [Abstract][Full Text] [Related]
19. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388 [TBL] [Abstract][Full Text] [Related]
20. Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients. Rosel P; Arranz B; Vallejo J; Alvarez P; Menchon JM; Palencia T; Navarro MA J Affect Disord; 1999; 52(1-3):225-33. PubMed ID: 10357037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]